Is a Surprise Coming for Compugen This Earnings Season?
CGEN Stock | USD 1.59 0.02 1.24% |
About 61% of Compugen's investor base is looking to short. The analysis of overall sentiment of trading Compugen stock suggests that many investors are alarmed at this time. Compugen's investing sentiment overview a quick insight into current market opportunities from investing in Compugen. Many technical investors use Compugen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Compugen |
Compugen is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Read at zacks.com
Compugen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Compugen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Compugen Fundamental Analysis
We analyze Compugen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compugen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compugen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Compugen is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Compugen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Compugen stock to make a market-neutral strategy. Peer analysis of Compugen could also be used in its relative valuation, which is a method of valuing Compugen by comparing valuation metrics with similar companies.
Peers
Compugen Related Equities
PHGE | Biomx | 18.33 | ||||
ICCC | ImmuCell | 10.75 | ||||
SANA | Sana Biotechnology | 9.02 | ||||
CLGN | Collplant Biotechnologies | 5.41 | ||||
CANF | Can Fite | 4.76 | ||||
BLRX | BioLineRx | 3.45 | ||||
EDIT | Editas Medicine | 1.82 | ||||
ANNX | Annexon | 0.94 | ||||
BEAM | Beam Therapeutics | 0.63 | ||||
PLUR | Pluri | 0.54 | ||||
ITOS | Iteos Therapeutics | 0.12 | ||||
CRBU | Caribou Biosciences | 0.45 | ||||
ALLO | Allogene Therapeutics | 0.80 | ||||
EVGN | Evogene | 4.73 |
Check out Compugen Hype Analysis, Compugen Correlation and Compugen Performance. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 | Revenue Per Share 0.48 | Quarterly Revenue Growth 3.461 | Return On Assets (0.03) | Return On Equity (0.16) |
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.